In the Phase II trial report of fornix-DBS in patients with AD, patients with LOAD showed a trend of clinical benefit, while there was a trend of faster cognitive deterioration in patients with EOAD (Lozano et al., 2016 ).
← all excerpts
Deep Brain Stimulation: A Potential Treatment for Dementia in Alzheimer's Disease (AD) and Parkinson's Disease Dementia (PDD).
1
—
—